General Information, Hemostasis/Coagulation

New Test: APTT Direct Thrombin Inhibitor

Effective Wednesday, August 17, 2022, the Coagulation Department at Spectrum Health Reference Laboratory (SHRL) will go-live with the Epic orderable APTT Direct Thrombin Inhibitor [LAB1230880]. 

This orderable is intended for patients on direct thrombin inhibitors (DTIs) which include argatroban, bivalirudin, and dabigatran.  This test will not reflex to Unfractionated Heparin Level (UFH, [LAB3389]) if no endpoint is achieved.

For collection instructions, please refer to the lab catalog.

For questions around this test, please contact the Coagulation Department using the “contact us” link above. If your need is urgent, please contact the Lab Call Center.

TEST INFORMATION

APTT Direct Thrombin Inhibitor [LAB1230880], CPT #85730

Previous Post Next Post

You Might Also Like

No Comments

Leave a Reply

five × 5 =